Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2889 results

Sort By:

Effect of the Addition of Adenosine on Myocardial Protection During Cardiopulmonary Bypass

Study ID: NCT07426237
Start Date: 2026-03-30
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

60

Intervention / Treatment

Adenoseins

Placebo (sterile distilled water)

Sponsor

Our Lady of Conception Hospital

Source: clinicaltrials.gov

Share:
Add to list

Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy

Study ID: NCT06437431
Start Date: 2026-09
End Date: 2030-10
Study Type

Interventional

Study Phase

Phase3

No. of Participants

304

Intervention / Treatment

glenzocimab

placebo

Sponsor

Adolphe de Rothschild Ophthalmological Foundation

Source: clinicaltrials.gov

Share:
Add to list

Incidence of Postoperative Diaphragmatic Dysfunction in Pregnant Women With Preeclampsia

Study ID: NCT07443345
Start Date: 2026-03-15
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

52

Intervention / Treatment
Sponsor

Cairo University

Source: clinicaltrials.gov

Share:
Add to list

Yoga, Meditation and Mindful Eating Intervention in University Students

Study ID: NCT07280078
Start Date: 2026-07
End Date: 2026-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Yoga, Meditation, and Mindful Eating

Sponsor

University of Antioquia

Source: clinicaltrials.gov

Share:
Add to list

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Study ID: NCT06694454
Start Date: 2026-03-08
End Date: 2034-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

azacytidine

carboplatin

paclitaxel

durvalumab

cisplatin

gemcitabine

pemetrexed

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus

Study ID: NCT07149402
Start Date: 2026-08-30
End Date: 2027-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

Study ID: NCT07261657
Start Date: 2026-09-02
End Date: 2032-09-02
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

8

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Leukapheresis

Magnetic Resonance Imaging

Nogapendekin Alfa Inbakicept

X-Ray Imaging

Sponsor

Northwestern University

Source: clinicaltrials.gov

Share:
Add to list

Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial

Study ID: NCT07178301
Start Date: 2026-03-20
End Date: 2031-03-20
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Computed Tomography

Nasopharyngeal Laryngoscopy

Positron Emission Tomography

Administration Questionnaire

Radiation Therapy

Sponsor

Northwestern University

Source: clinicaltrials.gov

Share:
Add to list

Release Kinetics of rhBMP-2 Using E-PRF as an Autologous Carrier: An In Vitro Analysis

Study ID: NCT04670965
Start Date: 2026-04
End Date: 2028-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

E-PRF/rhBMP-2 (similar ratios)

E-PRF/ACS/rhBMP-2

rhBMP-2/E-PRF

E-PRF only

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Evaluating the Delivery and Effects of THC Vaping Liquids in the Bloodstream

Study ID: NCT06334016
Start Date: 2026-03-15
End Date: 2028-03-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

60

Intervention / Treatment

Biospecimen Collection

Cannabis sativa Extract

Nicotine

Placebo Administration

Administration Questionnaire

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list